KRUSE BO

PrivateCIK: 1752940
Location

NEW YORK, NY

KRUSE BO (EVP, CFO, Secy & Treas.) sold 22.2% of their position (60K shares) of Y-MABS THERAPEUTICS, INC. on the open market

Open‑market sale worth $723.1K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 2 sales
InsiderKRUSE BOCIK 1752940
IssuerY-MABS THERAPEUTICS, INC.CIK 1722964
DirectorOfficer· EVP, CFO, Secy & Treas.
Since Sep 2018
-60K
Net shares
Net seller
$723.1K
Total sold
2
Open market trades
0B · 2S
6
Total transactions
60K acquired · 120K disposed
Non-Derivative Transactions4

Common Stock

Direct
M · Option Exercise

Shares

+28.63K

Price / share

$2.00

Trade value

$57.26K

% of position

13.6%
5/30/2024
210.88K239.51K

Common Stock

Direct
S · Sale

Shares

28.63K

Price / share

$12.03

Trade value

$344.41K

% of position

12.0%
5/30/2024
239.51K210.88K

Common Stock

Direct
M · Option Exercise

Shares

+31.37K

Price / share

$2.00

Trade value

$62.74K

% of position

14.9%
5/31/2024
210.88K242.25K

Common Stock

Direct
S · Sale

Shares

31.37K

Price / share

$12.07

Trade value

$378.65K

% of position

12.9%
5/31/2024
242.25K210.88K
Total

Net shares

+0.00

Net value

-$603.05K

Derivative Transactions2

Employee Stock Option (right to buy)

Direct
M · Option Exercise
Converts to

Common Stock

28.63K shares

Shares

28.63K

Strike price

2.00

Held after

271.37K

Exercisable

5/30/2024

Employee Stock Option (right to buy)

Direct
M · Option Exercise
Converts to

Common Stock

31.37K shares

Shares

31.37K

Strike price

2.00

Held after

240K

Exercisable

5/31/2024
KRUSE BO — Insider Transaction (Form 4) Filed May 31, 2024 | Finecho